HCPCS Index Logo

HCPCS Codes Alphabetical Index

— M —  /  — M0 —

M0001 — Advancing cancer care mips value pathways
Code added date: 20230101
Code effective date: 20230101
M0001 in HTML format HTML  |  M0001 in PDF (Portable Document Format) PDF  |  M0001 in plain Text format TXT
M0002 — Optimal care for kidney health mips value pathways
Code added date: 20230101
Code effective date: 20230101
M0002 in HTML format HTML  |  M0002 in PDF (Portable Document Format) PDF  |  M0002 in plain Text format TXT
M0003 — Optimal care for patients with episodic neurological conditions mips value pathways
Code added date: 20230101
Code effective date: 20250101
M0003 in HTML format HTML  |  M0003 in PDF (Portable Document Format) PDF  |  M0003 in plain Text format TXT
M0004 — Quality care for patients with neurological conditions mips value pathway
Code added date: 20230101
Code effective date: 20250101
M0004 in HTML format HTML  |  M0004 in PDF (Portable Document Format) PDF  |  M0004 in plain Text format TXT
M0005 — Value in primary care mips value pathway
Code added date: 20230101
Code effective date: 20240101
M0005 in HTML format HTML  |  M0005 in PDF (Portable Document Format) PDF  |  M0005 in plain Text format TXT
M0010 — Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
Code added date: 20230401
Code effective date: 20230401
M0010 in HTML format HTML  |  M0010 in PDF (Portable Document Format) PDF  |  M0010 in plain Text format TXT
M0064 — Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders
Code added date: 19920101
Code effective date: 20150101
M0064 in HTML format HTML  |  M0064 in PDF (Portable Document Format) PDF  |  M0064 in plain Text format TXT
M0075 — Cellular therapy
Code added date: 19860101
Code effective date: 19960101
M0075 in HTML format HTML  |  M0075 in PDF (Portable Document Format) PDF  |  M0075 in plain Text format TXT
M0076 — Prolotherapy
Code added date: 19860101
Code effective date: 19960101
M0076 in HTML format HTML  |  M0076 in PDF (Portable Document Format) PDF  |  M0076 in plain Text format TXT
M0100 — Intragastric hypothermia using gastric freezing
Code added date: 19860101
Code effective date: 20040101
M0100 in HTML format HTML  |  M0100 in PDF (Portable Document Format) PDF  |  M0100 in plain Text format TXT
M0201 — Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home
Code added date: 20210608
Code effective date: 20240101
M0201 in HTML format HTML  |  M0201 in PDF (Portable Document Format) PDF  |  M0201 in plain Text format TXT
M0220 — Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring
Code added date: 20211208
Code effective date: 20241213
M0220 in HTML format HTML  |  M0220 in PDF (Portable Document Format) PDF  |  M0220 in plain Text format TXT
M0221 — Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date: 20211208
Code effective date: 20241213
M0221 in HTML format HTML  |  M0221 in PDF (Portable Document Format) PDF  |  M0221 in plain Text format TXT
M0222 — Intravenous injection, bebtelovimab, includes injection and post administration monitoring
Code added date: 20220211
Code effective date: 20241213
M0222 in HTML format HTML  |  M0222 in PDF (Portable Document Format) PDF  |  M0222 in plain Text format TXT
M0223 — Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date: 20220211
Code effective date: 20241213
M0223 in HTML format HTML  |  M0223 in PDF (Portable Document Format) PDF  |  M0223 in plain Text format TXT
M0224 — Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring
Code added date: 20240322
Code effective date: 20240322
M0224 in HTML format HTML  |  M0224 in PDF (Portable Document Format) PDF  |  M0224 in plain Text format TXT
M0235 — Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date: 20251001
Code effective date: 20251001
M0235 in HTML format HTML  |  M0235 in PDF (Portable Document Format) PDF  |  M0235 in plain Text format TXT
M0236 — Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date: 20251001
Code effective date: 20251001
M0236 in HTML format HTML  |  M0236 in PDF (Portable Document Format) PDF  |  M0236 in plain Text format TXT
M0237 — Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Code added date: 20250124
Code effective date: 20250124
M0237 in HTML format HTML  |  M0237 in PDF (Portable Document Format) PDF  |  M0237 in plain Text format TXT
M0238 — Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Code added date: 20250124
Code effective date: 20250124
M0238 in HTML format HTML  |  M0238 in PDF (Portable Document Format) PDF  |  M0238 in plain Text format TXT
M0239 — Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring
Code added date: 20201109
Code effective date: 20210417
M0239 in HTML format HTML  |  M0239 in PDF (Portable Document Format) PDF  |  M0239 in plain Text format TXT
M0240 — Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
Code added date: 20210730
Code effective date: 20241213
M0240 in HTML format HTML  |  M0240 in PDF (Portable Document Format) PDF  |  M0240 in plain Text format TXT
M0241 — Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
Code added date: 20210730
Code effective date: 20241213
M0241 in HTML format HTML  |  M0241 in PDF (Portable Document Format) PDF  |  M0241 in plain Text format TXT
M0243 — Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
Code added date: 20201121
Code effective date: 20241213
M0243 in HTML format HTML  |  M0243 in PDF (Portable Document Format) PDF  |  M0243 in plain Text format TXT
M0244 — Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date: 20210506
Code effective date: 20241213
M0244 in HTML format HTML  |  M0244 in PDF (Portable Document Format) PDF  |  M0244 in plain Text format TXT
M0245 — Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
Code added date: 20210209
Code effective date: 20231214
M0245 in HTML format HTML  |  M0245 in PDF (Portable Document Format) PDF  |  M0245 in plain Text format TXT
M0246 — Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency
Code added date: 20210506
Code effective date: 20231214
M0246 in HTML format HTML  |  M0246 in PDF (Portable Document Format) PDF  |  M0246 in plain Text format TXT
M0247 — Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
Code added date: 20210526
Code effective date: 20241213
M0247 in HTML format HTML  |  M0247 in PDF (Portable Document Format) PDF  |  M0247 in plain Text format TXT
M0248 — Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date: 20210526
Code effective date: 20241213
M0248 in HTML format HTML  |  M0248 in PDF (Portable Document Format) PDF  |  M0248 in plain Text format TXT
M0249 — Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Code added date: 20210624
Code effective date: 20210624
M0249 in HTML format HTML  |  M0249 in PDF (Portable Document Format) PDF  |  M0249 in plain Text format TXT
M0250 — Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Code added date: 20210624
Code effective date: 20210624
M0250 in HTML format HTML  |  M0250 in PDF (Portable Document Format) PDF  |  M0250 in plain Text format TXT
M0300 — Iv chelation therapy (chemical endarterectomy)
Code added date: 19860101
Code effective date: 19960101
M0300 in HTML format HTML  |  M0300 in PDF (Portable Document Format) PDF  |  M0300 in plain Text format TXT
M0301 — Fabric wrapping of abdominal aneurysm
Code added date: 19860101
Code effective date: 20040101
M0301 in HTML format HTML  |  M0301 in PDF (Portable Document Format) PDF  |  M0301 in plain Text format TXT